At-home sleep monitoring using generic ear-EEG

Evaluating the Electroencephalographic Signal Quality of an In-Ear Wearable Device

Wearable in-ear electroencephalographic (EEG) devices hold significant promise for advancing brain monitoring technologies into everyday applications. However, despite the current availability of several in-ear EEG devices in the market, there remains a critical need for robust validation against established clinical-grade systems. In this study, we carried out a detailed examination of the signal performance of a mobile in-ear EEG device from Naox Technologies. Our investigation had two main goals: firstly, evaluating the hardware circuit's reliability through simulated EEG signal experiments and, secondly, conducting a thorough comparison between the in-ear EEG device and gold-standard EEG monitoring equipment. This comparison assesses correlation coefficients with recognized physiological patterns during wakefulness and sleep, including alpha rhythms, eye artifacts, slow waves, spindles, and sleep stages. Our findings support the feasibility of using this in-ear EEG device for brain activity monitoring, particularly in scenarios requiring enhanced comfort and user-friendliness in various clinical and research settings.

Sleep assessment using EEG-based wearables - A systematic review

Polysomnography (PSG) is the reference standard of sleep measurement, but is burdensome for the participant and labor intensive. Affordable electroencephalography (EEG)-based wearables are easy to use and are gaining popularity, yet selecting the most suitable device is a challenge for clinicians and researchers. In this systematic review, we aim to provide a comprehensive overview of available EEG-based wearables to measure human sleep. For each wearable, an overview will be provided regarding validated population and reported measurement properties. A systematic search was conducted in the databases OVID MEDLINE, Embase.com and CINAHL. A machine learning algorithm (ASReview) was utilized to screen titles and abstracts for eligibility. In total, 60 papers were selected, covering 34 unique EEG-based wearables. Feasibility studies indicated good tolerance, high compliance, and success rates. The 42 included validation studies were conducted across diverse populations and showed consistently high accuracy in sleep staging detection. Therefore, the recent advancements in EEG-based wearables show great promise as alternative for PSG and for at-home sleep monitoring. Users should consider factors like user-friendliness, comfort, and costs, as these devices vary in features and pricing, impacting their suitability for individual needs.

Remote Wearable Neuroimaging Devices for Health Monitoring and Neurophenotyping: A Scoping Review

Digital health tracking is a source of valuable insights for public health research and consumer health technology. The brain is the most complex organ, containing information about psychophysical and physiological biomarkers that correlate with health. Specifically, recent developments in electroencephalogram (EEG), functional near-infra-red spectroscopy (fNIRS), and photoplethysmography (PPG) technologies have allowed the development of devices that can remotely monitor changes in brain activity. The inclusion criteria for the papers in this review encompassed studies on self-applied, remote, non-invasive neuroimaging techniques (EEG, fNIRS, or PPG) within healthcare applications. A total of 23 papers were reviewed, comprising 17 on using EEGs for remote monitoring and 6 on neurofeedback interventions, while no papers were found related to fNIRS and PPG. This review reveals that previous studies have leveraged mobile EEG devices for remote monitoring across the mental health, neurological, and sleep domains, as well as for delivering neurofeedback interventions. With headsets and ear-EEG devices being the most common, studies found mobile devices feasible for implementation in study protocols while providing reliable signal quality. Moderate to substantial agreement overall between remote and clinical-grade EEGs was found using statistical tests. The results highlight the promise of portable brain-imaging devices with regard to continuously evaluating patients in natural settings, though further validation and usability enhancements are needed as this technology develops.

Advancements in Wearable EEG Technology for Improved Home-Based Sleep Monitoring and Assessment: A Review

Sleep is a fundamental aspect of daily life, profoundly impacting mental and emotional well-being. Optimal sleep quality is vital for overall health and quality of life, yet many individuals struggle with sleep-related difficulties. In the past, polysomnography (PSG) has served as the gold standard for assessing sleep, but its bulky nature, cost, and the need for expertise has made it cumbersome for widespread use. By recognizing the need for a more accessible and user-friendly approach, wearable home monitoring systems have emerged. EEG technology plays a pivotal role in sleep monitoring, as it captures crucial brain activity data during sleep and serves as a primary indicator of sleep stages and disorders. This review provides an overview of the most recent advancements in wearable sleep monitoring leveraging EEG technology. We summarize the latest EEG devices and systems available in the scientific literature, highlighting their design, form factors, materials, and methods of sleep assessment. By exploring these developments, we aim to offer insights into cutting-edge technologies, shedding light on wearable EEG sensors for advanced at-home sleep monitoring and assessment. This comprehensive review contributes to a broader perspective on enhancing sleep quality and overall health using wearable EEG sensors.

Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies

Parkinson disease (PD) is a complex neurodegenerative disorder that afflicts over 10 million people worldwide, resulting in debilitating motor and cognitive impairment. In the United States alone (with approximately 1 million cases), the economic burden for treating and caring for persons with PD exceeds US $50 billion and myriad therapeutic approaches are under development, including both symptomatic- and disease-modifying agents. The challenges presented in addressing PD are compounded by observations that numerous, statistically distinct patient phenotypes present with a wide variety of motor and nonmotor symptomatic profiles, varying responses to current standard-of-care symptom-alleviating medications (L-DOPA and dopaminergic agonists), and different disease trajectories. The existence of these differing phenotypes highlights the opportunities in personalized approaches to symptom management and disease control. The prodromal period of PD can span across several decades, allowing the potential to leverage the unique array of composite symptoms presented to trigger early interventions. This may be especially beneficial as disease progression in PD (alongside Alzheimer disease and Huntington disease) may be influenced by biological processes such as oxidative stress, offering the potential for individual lifestyle factors to be tailored to delay disease onset. In this viewpoint, we offer potential scenarios where emerging diagnostic and monitoring strategies might be tailored to the individual patient under the tenets of P4 medicine (predict, prevent, personalize, and participate). These approaches may be especially relevant as the causative factors and biochemical pathways responsible for the observed neurodegeneration in patients with PD remain areas of fluid debate. The numerous observational patient cohorts established globally offer an excellent opportunity to test and refine approaches to detect, characterize, control, modify the course, and ultimately stop progression of this debilitating disease. Such approaches may also help development of parallel interventive strategies in other diseases such as Alzheimer disease and Huntington disease, which share common traits and etiologies with PD. In this overview, we highlight near-term opportunities to apply P4 medicine principles for patients with PD and introduce the concept of composite orthogonal patient monitoring.

A Versatile In-Ear Biosensing System and Body-Area Network for Unobtrusive Continuous Health Monitoring

To enable continuous, mobile health monitoring, body-worn sensors need to offer comparable performance to clinical devices in a lightweight, unobtrusive package. This work presents a complete versatile wireless electrophysiology data acquisition system (weDAQ) that is demonstrated for in-ear electroencephalography (EEG) and other on-body electrophysiology with user-generic dry-contact electrodes made from standard printed circuit boards (PCBs). Each weDAQ device provides 16 recording channels, driven right leg (DRL), a 3-axis accelerometer, local data storage, and adaptable data transmission modes. The weDAQ wireless interface supports deployment of a body area network (BAN) capable of aggregating various biosignal streams over multiple worn devices simultaneously, on the 802.11n WiFi protocol. Each channel resolves biopotentials ranging over 5 orders of magnitude with a noise level of 0.52 μVrms over a 1000-Hz bandwidth, and a peak SNDR of 119 dB and CMRR of 111 dB at 2 ksps. The device leverages in-band impedance scanning and an input multiplexer to dynamically select good skin contacting electrodes for reference and sensing channels. In-ear and forehead EEG measurements taken from subjects captured modulation of alpha brain activity, electrooculogram (EOG) characteristic eye movements, and electromyogram (EMG) from jaw muscles. Simultaneous ECG and EMG measurements were demonstrated on multiple, freely-moving subjects in their natural office environment during periods of rest and exercise. The small footprint, performance, and configurability of the open-source weDAQ platform and scalable PCB electrodes presented, aim to provide the biosensing community greater experimental flexibility and lower the barrier to entry for new health monitoring research.